Molecular Imaging Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 10 Center Dr., Bethesda, MD 20892-1088, USA.
Nanomedicine (Lond). 2010 Jul;5(5):765-76. doi: 10.2217/nnm.10.49.
Biomedical optical imaging is rapidly evolving because of its desirable features of rapid frame rates, high sensitivity, low cost, portability and lack of radiation. Quantum dots are attractive as imaging agents owing to their high brightness, and photo- and bio-stability. Here, the current status of in vitro and in vivo real-time optical imaging with quantum dots is reviewed. In addition, we consider related nanocrystals based on solid-state semiconductors, including upconverting nanoparticles and bioluminescence resonance energy transfer quantum dots. These particles can improve the signal-to-background ratio for real-time imaging largely by suppressing background signal. Although toxicity and biodistribution of quantum dots and their close relatives remain prime concerns for translation to human imaging, these agents have many desirable features that should be explored for medical purposes.
生物医学光学成像是一种快速发展的技术,因为它具有快速帧率、高灵敏度、低成本、便携性和无辐射等优点。量子点因其高亮度、光稳定性和生物稳定性而成为有吸引力的成像剂。本文综述了量子点在体外和体内实时光学成像中的应用现状。此外,我们还考虑了基于固态半导体的相关纳米晶体,包括上转换纳米粒子和生物发光共振能量转移量子点。这些粒子可以通过抑制背景信号来大大提高实时成像的信号与背景比。尽管量子点及其类似物的毒性和生物分布仍是将其转化为人体成像的主要关注点,但这些试剂具有许多理想的特性,应该用于医学目的。